This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DSB | Ann: ASX Market Release - Removal from Official List | 29/08/17 | 0 | 375 | |||
|
|||||||
DSB | Ann: Suspension from Official Quotation - Annual Listing Fees | 22/08/17 | 0 | 259 | |||
|
|||||||
DSB | Ann: Letter to Shareholders | 21/08/17 | 0 | 380 | |||
|
|||||||
DSB | Ann: Letter to Shareholders - Administrators report to creditors | 11/08/17 | 0 | 285 | |||
|
|||||||
DSB | Ann: Letter to Shareholders | 28/06/17 | 0 | 399 | |||
|
|||||||
DSB | Ann: Administrators' Sale - Delta SBD Group | 07/06/17 | 0 | 569 | |||
|
|||||||
DSB | Ann: Trading Halt | 05/06/17 | 14 | 6.5K | |||
|
|||||||
DSB | Ann: Half Year Results Presentation | 01/06/17 | 5 | 2.5K | |||
|
See All Discussions